Your session is about to expire
← Back to Search
Combined Radiation and Chemotherapy for Pancreatic Cancer
Study Summary
This trial is testing a new cancer treatment that combines surgery and radiation therapy.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My cancer has spread beyond the pancreas.I cannot have the Whipple procedure.You are currently participating in another study with a drug or device that could affect the results of this clinical trial.I am willing to use birth control during the study.Imaging shows my cancer has spread to the duodenum, making me ineligible for SBRT.My cancer is in the body or tail of the pancreas.I am receiving initial treatment with a combination of chemotherapy drugs.I cannot receive SBRT treatment at JHU.I am eligible for a surgery assessment at JHU.I had surgery to rebuild an artery.My pancreatic cancer is considered operable according to NCCN guidelines.I can take care of myself and am up and about more than half of the day.I am older than 18 years.I am a candidate for a specific radiation therapy at JHU.I have had radiation therapy to my chest or abdomen.
- Group 1: Intra Operative Radiation Therapy (IORT) Group
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many individuals are enrolled in the trial at this juncture?
"Affirmative. According to clinicaltrials.gov, this research project is presently accepting volunteers and was first posted on May 6th 2022. The most recent update came June 3rd 2022 and the trial is currently seeking 25 participants from a single site."
Is it feasible to join this trial at the present moment?
"Per the records available on clinicaltrials.gov, this trial is presently recruiting participants with an initial posting date of May 6th 2022 and most recent update done on June 3rd 2022."
Has this medical technique been accepted by the FDA?
"Limited safety and efficacy data suggests that this medication's safety rating on a 1 - 3 scale is approximately 1. This evaluation stems from it being in its early Phase 1 trial stage."
Share this study with friends
Copy Link
Messenger